Navigation Links
Paragon Bioservices Appoints Dr. Vadim Klyushnichenko as Vice President of Preclinical Services and Process Development
Date:7/20/2011

BALTIMORE, July 20, 2011 /PRNewswire/ -- Paragon Bioservices, Inc., a Baltimore-based contract research and GMP manufacturing organization, announced today the appointment of Vadim Klyushnichenko, Ph.D. as Vice President, Preclinical Services and Process Development.  He will report to Paragon's President and CEO Marco Chacon, Ph.D.

Dr. Klyushnichenko has more than 15 years experience in biopharmaceutical project management, analytical development and formulation, process development, engineering and scale-up from pilot to GMP manufacturing, technology transfer and regulatory filing.

He developed his managerial and scientific background working as Vice President of Drug Development at both Terapio (Austin, TX) and Coldstream Laboratories, Lab Head at Wyeth BioPharma, and Senior Scientist positions at Epic Therapeutics (Baxter), Altus Biologics in Boston and Aventis/Sanofi Pasteur.

Dr. Klyushnichenko received his M.S., Engineering from Moscow Institute of Physics and Technology, and a  Ph.D. in Chemistry from the Shemyakin Institute of Bioorganic Chemistry in Moscow. His additional research in Analytical Biochemistry and Process Development includes the Humboldt University in Berlin, Dusseldorf University, and the Biotechnology Research Institute in Montreal.  He is also a Certified Professional Project Manager (PMP/PMI) and holds a Certificate of Special Studies (CSS) in Administration and Management from Harvard University.

Dr. Chacon stated, "We feel that Vadim will be a great addition to Paragon's team as we continue to add personnel, double our process development and GMP manufacturing and add fill-and-finish capabilities to our facility."

About Paragon Bioservices

Paragon Bioservices is a contract research and manufacturing organization (CMO) that provides a comprehensive portfolio of services—from research services and process development to cGMP manufacturing of monoclonal antibodies, therapeutic proteins, vaccines and VLPs, and stem cells.  The corporate focus is to bridge the translational divide and enable protein and cell-based therapeutics to move into clinical trials.

Media contacts:
Tiberend Strategic Advisors, Inc.
212-827-0020
Tamara Bright: tbright@tiberend.com
or
Claire Sojda: csojda@tiberend.com


'/>"/>
SOURCE Paragon Bioservices, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Paragon Bioservices to Partner and Exhibit at the 2011 BIO International Convention
2. Paragon Bioservices Launches Second Expansion to Celebrate its 20th Anniversary
3. ParagonRx Names Ellen M. Derrico To Chief Marketing Executive Post
4. HYCOR Appoints Sean-Xavier Neath as Chief Medical Officer to Support Expansion of Product Lines and Enhance Customer Support Offerings
5. CoLucid Appoints Thomas P. Mathers as Chief Executive Officer
6. Regulus Therapeutics Appoints Gregory Hannon, Ph.D. to Scientific Advisory Board
7. GenturaDx Appoints Senior Vice President of Research & Development
8. H. D. Smith Appoints Mark de Bruin Corporate Vice President Managed Care
9. OncoSec Medical Appoints Engineering Leader
10. Tris Pharma Appoints Vice President of Human Resources
11. Cepheid Appoints Vice President of Infectious Disease Research & Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 24, 2017 The Board of Directors of ... Report 2016 including the complete 2016 Annual Accounts with notes. ... Nordic Nanovector,s website in the section Investor Relations/Reports and presentations/Annual ... ... Kvåle, Chief Financial Officer Cell: +47-91-51-95-76 Email: ir@nordicnanovector.com ...
(Date:3/23/2017)... 23, 2017  Transportation Insight, a multi-modal lead logistics ... chain management firm with expertise serving clients in the ... Rick Zaffarano was named a 2017 Food ... by the only publication exclusively dedicated to covering the ... "Rick has brought to Transportation Insight a ...
(Date:3/23/2017)... , March 23, 2017 ... Pharmaceutical and Healthcare disease pipeline guide Primary Hyperoxaluria ... of the Primary Hyperoxaluria (Genito Urinary System And ... a rare condition characterized by recurrent kidney and ... a substance called oxalate. Symptoms include blood in ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... 24, 2017 , ... Mlynarek Insurance Agencies, a Detroit area ... owners across eastern Michigan, is connecting with the Oxford/Orion FISH Food Pantry for ... The Oxford/Orion FISH Food Pantry works to ensure homeless, hungry, and underprivileged families ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... that they are now offering treatments for sleep apnea and TMJ at their ... Sleep apnea , specifically the obstructive type, is increasingly being treated at ...
(Date:3/24/2017)... ... 2017 , ... Gastro Health (“GH”) ( http://www.gastrohealth.com ) ... colonoscopy at the HyGIeaCare® Center that is to be located adjacent to the ... The HyGIeaCare® Prep, cleared by the U.S. Food and Drug Administration (FDA), will ...
(Date:3/24/2017)... ... March 24, 2017 , ... “End Time GPS”: a dauntless and enlightened ... “End Time GPS” is the creation of published author, Wesley Gerboth, a World War ... munitions and space-vehicle projects. Now, at age ninety-one, he shares the Wisdom God bestowed ...
(Date:3/23/2017)... NC & Seattle, WA (PRWEB) , ... March 23, 2017 , ... ... public health emergency and now estimates that there could be four million Zika-related cases ... growing epidemics to date with numbers of US cases reported per year skyrocketing to ...
Breaking Medicine News(10 mins):